Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Alzheimers Disease and other Cognitive Disorders
Resources
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Health Tip: Identifying Vascular DementiaOne Type of Dementia Is Especially CostlyA More Accurate Predictor for Alzheimer's?Failing Sense of Smell Tied to Dementia RiskMagnesium Levels Tied to Dementia RiskIs Dementia Declining Among Older Americans?Intracranial Pressure Monitoring No Benefit in Pediatric TBIGender-Specific High-Risk 'Window' Seen in Alzheimer'sWomen at Risk for Alzheimer's Face Critical 10-Year Window, Study SaysDo Fewer Nightly Dreams Mean Higher Dementia Risk in Seniors?Dementia Care: A Huge Financial Burden for U.S. FamiliesPopular Heartburn Drugs Don't Raise Risk of Alzheimer's: StudyFamilies Shoulder Majority of Costs Related to Dementia CareMidlife Vascular Risk Factors Tied to Increased Risk of DementiaBlood Pressure Fluctuations Tied to Dementia Risk in StudyMidlife Behaviors May Affect Your Dementia RiskTraveling With Dementia: Tips for Family CaregiversHigher Risk of Dementia Seen in Those Hailing From 'Stroke Belt'Health Tip: Alzheimer's Affects SleepIncreased Dementia Risk With Hearing Loss in Older AdultsNoninvasive Brain Test May Pinpoint Type of DementiaTargeting 9 Risk Factors Could Prevent 1 in 3 Dementia Cases: StudyAAIC: Rx + Training Shows Benefit in Advanced Alzheimer'sAAIC: Alzheimer Biomarkers Up With Sleep Disordered BreathingDozens of Potential Alzheimer's Meds in the PipelineSpecial Training Plus Medication Might Help People With Advanced Alzheimer'sOne Social Hour a Week Can Help Someone With DementiaSleep Problems: An Early Warning Sign of Alzheimer's?Severe Head Injury May Raise Dementia Risk Years LaterPPIs Not Found to Raise Risk of Alzheimer's DiseasePopular Heartburn Meds Don't Raise Alzheimer's Risk: StudyLifestyle Changes Might Prevent or Slow DementiaSevere Headaches Plague Vets With Traumatic Brain InjuriesSticky Brain 'Plaques' Implicated in Alzheimer's Again'Making the Best of It': Families Face the Heavy Burden of Alzheimer'sCognitive Decline Linked to Visual Field VariabilityAlzheimer's Deaths Jump 55 Percent: CDCLife Expectancy Slighter Shorter With Parkinson's, DementiaLow Body Mass Index Not Risk Factor for Alzheimer's DiseaseThin People Not More Prone to Alzheimer's, Study FindsWives, Daughters Shoulder Most of Alzheimer's Care BurdenGene Mutation May Speed Alzheimer's DeclineSilent Seizures May Contribute to Alzheimer's Pathology'Silent' Seizures Tied to Alzheimer's SymptomsPsychiatric Scars of Wartime Brain Injury May Linger for YearsMany Patients With Alzheimer's Disease Discontinue AChEIsMicrovascular Endothelial Dysfunction Can Predict DementiaAntipsychotic Medication Use Can Be Reduced in Dementia PatientsPast Psychiatric Disorders Do Not Raise Risk of Alzheimer's DiseasePast Psychiatric Ills Don't Raise Alzheimer's Risk: Study
Questions and AnswersLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

A More Accurate Predictor for Alzheimer's?

HealthDay News
by -- Robert Preidt
Updated: Sep 29th 2017

new article illustration

FRIDAY, Sept. 29, 2017 (HealthDay News) -- A new test that checks for multiple gene variants linked with Alzheimer's disease may be more effective than testing for a single genetic variant, a new study suggests.

The genetic variant APOE E4 is regarded as the strongest genetic predictor of whether a person is likely to develop the memory-robbing disease. But it's present in only 10 to 15 percent of people. And recent research suggests its impact has been overestimated, the study authors said.

They developed a test that estimates the risk of Alzheimer's in the 85 to 90 percent of people who don't have at least one copy of APOE E4 but still have other gene variants that put them at risk of Alzheimer's. The test is called the polygenic hazard score (PHS).

The researchers reviewed five years of data from nearly 1,100 Americans without dementia. They concluded that the new test could predict how long it would take the study participants to progress to Alzheimer's disease and the speed of their mental decline.

"Beyond APOE E4 by itself, our polygenic hazard score can identify cognitively normal and mildly impaired older folks who are at greatest risk for developing Alzheimer's-associated clinical decline over time," said study first author Chin Hong Tan. A postdoctoral scholar at the University of California, San Francisco, Tan made the comments said in a school news release.

Autopsies on people who had Alzheimer's found that a higher PHS was associated with more Alzheimer's-related amyloid plaque in the brain. These people also reportedly had faster declines on tests of mental skills while living.

Older people with the highest PHS had the highest rates of Alzheimer's, regardless of their APOE E4 status, the study authors said.

"Our findings have strong implications for [research] trials in Alzheimer's, as well as direct-to-consumer genetic tests, some of which have recently received FDA clearance," said study co-author Anders Dale, a professor of neurosciences and radiology at the University of California, San Diego.

The study was published recently in the Annals of Neurology.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.